These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18341456)

  • 1. Prescribing of psychostimulant medications for attention deficit hyperactivity disorder in children: differences between clinical specialties.
    Preen DB; Calver J; Sanfilippo FM; Bulsara M; Holman CD
    Med J Aust; 2008 Mar; 188(6):337-9. PubMed ID: 18341456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
    Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
    Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatricians' decision making about prescribing stimulant medications for children with attention-deficit/hyperactivity disorder.
    Chow SJ; Sciberras E; Gillam LH; Green J; Efron D
    Child Care Health Dev; 2014 May; 40(3):301-8. PubMed ID: 23445484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists.
    Efron D; Hiscock H; Sewell JR; Cranswick NE; Vance AL; Tyl Y; Luk ES
    Pediatrics; 2003 Feb; 111(2):372-5. PubMed ID: 12563066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.
    Preen DB; Calver J; Sanfilippo FM; Bulsara M; Holman CD
    Aust N Z J Public Health; 2007 Apr; 31(2):120-6. PubMed ID: 17461001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Patterns of Commonly Prescribed Psychotropic Medications to Young People.
    Sultan RS; Correll CU; Schoenbaum M; King M; Walkup JT; Olfson M
    J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):158-165. PubMed ID: 29376743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practitioner characteristics and the treatment of children and adolescents with attention deficit hyperactivity disorder.
    Mitchell PB; Levy F; Hadzi-Pavlovic D; Concannon PE; Hutchins P; Mulcahy DL; Clarke SD; Salmelainen PA; Warner A; Hughes CF
    J Paediatr Child Health; 2012 Jun; 48(6):483-9. PubMed ID: 22111981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study.
    Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ
    J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I; Lee MS; Lee EK; Shin JY
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009-2012: focus on children, adolescents and prescriber specialty.
    Karanges EA; Stephenson CP; McGregor IS
    Aust N Z J Psychiatry; 2014 Oct; 48(10):917-31. PubMed ID: 24927734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood Attention-Deficit/Hyperactivity Disorder Prescribing by Prescriber Type and Specialty in Oregon Medicaid.
    Klein TA; Panther S; Woo T; Odom-Maryon T; Daratha K
    J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):548-54. PubMed ID: 27135134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
    Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prescribing of stimulants for ADHD in Nordland County].
    Asheim H; Nilsen KB; Johansen K; Furu K
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2360-2. PubMed ID: 17895938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulant prescribing for the treatment of ADHD in Western Australia: socioeconomic and remoteness differences.
    Calver J; Preen D; Bulsara M; Sanfilippo F
    Med J Aust; 2007 Feb; 186(3):124-7. PubMed ID: 17309400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulant prescribing for attention deficit hyperactivity disorder (ADHD): what guides clinicians in their choice of an upper limit for dose titration?
    Poulton AS; Paterson R
    Australas Psychiatry; 2020 Oct; 28(5):568-572. PubMed ID: 32093503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.